标题
Rational design of small molecules as vaccine adjuvants
作者
关键词
-
出版物
Science Translational Medicine
Volume 6, Issue 263, Pages 263ra160-263ra160
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2014-11-20
DOI
10.1126/scitranslmed.3009980
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multifunctional PLGA-Based Nanoparticles Encapsulating Simultaneously Hydrophilic Antigen and Hydrophobic Immunomodulator for Mucosal Immunization
- (2013) Charlotte Primard et al. MOLECULAR PHARMACEUTICS
- Human Vaccines & Immunotherapeutics: News
- (2013) Eva M. Riedmann Human Vaccines & Immunotherapeutics
- Cubosomes containing the adjuvants imiquimod and monophosphoryl lipid A stimulate robust cellular and humoral immune responses
- (2012) S.B. Rizwan et al. JOURNAL OF CONTROLLED RELEASE
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- Development of an Automated, High-Throughput Bactericidal Assay That Measures Cellular Respiration as a Survival Readout for Neisseria meningitidis
- (2011) Puiying A. Mak et al. Clinical and Vaccine Immunology
- A Point Mutation in the Amino Terminus of TLR7 Abolishes Signaling without Affecting Ligand Binding
- (2011) Carlo Iavarone et al. JOURNAL OF IMMUNOLOGY
- New adjuvants for human vaccines
- (2010) M Lamine Mbow et al. CURRENT OPINION IN IMMUNOLOGY
- Genetic shifts ofNeisseria meningitidisserogroup B antigens and the quest for a broadly cross-protective vaccine
- (2010) Xilian Bai et al. Expert Review of Vaccines
- Identification of Novel Synthetic Toll-like Receptor 2 Agonists by High Throughput Screening
- (2010) Yue Guan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pemphigus-like lesions induced by imiquimod
- (2009) A. Bauza et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Fast Tracking the Vaccine Licensure Process to Control an Epidemic of Serogroup B Meningococcal Disease in New Zealand
- (2009) Diana Lennon et al. CLINICAL INFECTIOUS DISEASES
- The path to a successful vaccine adjuvant – ‘The long and winding road’
- (2009) Derek T. O’Hagan et al. DRUG DISCOVERY TODAY
- TLR9 agonist, but not TLR7/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity
- (2009) Teresa R. Johnson et al. VACCINE
- A phase II dose-ranging study of topical resiquimod to treat actinic keratosis
- (2008) R.-M. Szeimies et al. BRITISH JOURNAL OF DERMATOLOGY
- Interlaboratory Comparison of Results of an Anthrax Lethal Toxin Neutralization Assay for Assessment of Functional Antibodies in Multiple Species
- (2008) K. S. Omland et al. Clinical and Vaccine Immunology
- Clinical investigations of Toll-like receptor agonists
- (2008) Thomas Meyer et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Molecular and cellular signatures of human vaccine adjuvants
- (2008) F. Mosca et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started